Naturalendo Tech Co., Ltd. (KOSDAQ:168330)

Market Cap	93.77B +98.3%
Revenue (ttm)	21.87B -9.0%
Net Income	-3.29B
EPS	-104.14
Shares Out	31.57M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	78,039
Average Volume	139,131
Open	2,920.00
Previous Close	2,920.00
Day's Range	2,890.00 - 2,995.00
52-Week Range	1,278.00 - 6,300.00
Beta	0.03
RSI	56.01
Earnings Date	Mar 17, 2026

About Naturalendo Tech

Naturalendo Tech Co., Ltd. engages in the research, development, manufacture, and sale of physical chemistry and biology, biological agents, food additives, and health functional food in South Korea. The company offers EstroG-100, a functional raw material for women's menopause; HabaNova, a diet ingredient; YGF 251, a phyto height growth booster; NET 2401, a multiway sleep-wake cycle regulator; Stauntonia hexaphylla Fruit Extract, an anti-inflammatory superfood; Q.186 complex for improving male menopause; NET 1701, a men’s prostate and urinary ...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2001
• Employees: 81
• Stock Exchange: KOSDAQ
• Ticker Symbol: 168330

Financial Performance

In 2024, Naturalendo Tech's revenue was 22.26 billion, an increase of 18.48% compared to the previous year's 18.79 billion. Losses were -3.89 billion, -11.04% less than in 2023.